Ignite Creation Date:
2024-05-06 @ 7:53 PM
Last Modification Date:
2024-10-26 @ 3:16 PM
Study NCT ID:
NCT06178445
Status:
RECRUITING
Last Update Posted:
2024-05-30
First Post:
2023-12-11
Brief Title:
Efficacy and Safety of GemCis Plus Trastuzumab Plus Pembrolizumab in Previously Untreated HER2-positive Biliary Tract Cancer
Sponsor:
Organization:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest